Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-10-30

Clinical Trial Update: Evaluation of Eflornithine on Facial and Forearm Skin [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating eflornithine for facial and forearm hirsutism has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Eflornithine (eflornithine)

Snippet

Sponsor: Allergan | Conditions: Hirsutism | Phase 4 | Status: COMPLETED